Biomarkers in gastrointestinal cancers

Rami Badreddine, Kenneth K. Wang

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


We have summarized the characteristics of the clinically useful or potentially useful biomarkers in a number of GI cancers. This field is growing, and the predictive and diagnostic value of the biomarkers as a measure of carcinogenesis is still in evolution. It is essential for the clinician to have an understanding of the basic molecular biology behind GI cancers because, in the future, many clinicians will be routinely ordering biomarker testing as part of patient screening. The biomarkers in GI cancers are useful not only for screening, diagnosis, and prognosis but also for prediction of the response to mechanism-based interventions, such as chemoprevention. Ongoing assessment of these diagnostic and predictive factors will probably lead to a change in the current staging of many GI cancers.

Original languageEnglish (US)
Pages (from-to)2106-2110
Number of pages5
JournalAmerican Journal of Gastroenterology
Issue number8
StatePublished - Aug 2008

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Biomarkers in gastrointestinal cancers'. Together they form a unique fingerprint.

Cite this